血漿誘導体の世界市場レポート 2025年

血漿誘導体市場規模は、今後数年間で力強い成長が見込まれます。2029年にはCAGR9.4%で804億2,000万米ドルに成長します。予測期間の成長は、希少疾患治療の出現、慢性疾患の増加、ヘルスケア支出の増加、患者中心の治療アプローチ、ヘルスケアインフラの成長に起因しています。予測期間における主な動向としては、分画技術の進歩、患者中心のアプローチ、共同研究・提携、神経学における用途の拡大、血漿分画の技術革新などが挙げられます。

免疫不全症の罹患率の上昇が血漿誘導体市場の成長を牽引すると予想されます。免疫不全障害は、免疫系が全体的または部分的に弱まる疾患です。血漿誘導体は、免疫不全障害を含む様々な病状の治療に利用されています。タンパク質と塩からなる血漿には100種類以上のタンパク質が含まれており、特に免疫グロブリンは原発性免疫不全症の治療に重要です。栄養不良や栄養失調などの要因は、マクロ栄養素や微量栄養素の欠乏を招き、免疫不全を引き起こします。例えば、2022年3月、アレルギー・喘息・臨床免疫学（Allergy, Asthma &Clinical Immunology）は、最も流行している疾患は共通変種性免疫不全症（CVID）であり、米国では16.6％、国際的には12.9％、世界的には13.9％が罹患していると報告しました。したがって、免疫不全疾患の有病率の増加が血漿誘導体市場の成長に寄与しています。

外傷や事故事例の増加は、血漿誘導体市場の成長をさらに加速させると予想されます。外傷や事故事例は、予期せぬ出来事によって個人が身体的な損傷や危害を被る状況を含みます。血漿誘導体はこのような場面で、凝固因子の補充、出血性ショックの治療、止血と凝固制御の補助、体液の補充、創傷治癒のサポート、体液バランスを維持しながらの浮腫管理に使用されます。例えば、2024年4月、米国政府機関である道路交通安全局は、2022年に注意力散漫運転による事故で3,308人が死亡し、約289,310人が負傷したと報告しました。このように、外傷や事故事例の増加が血漿誘導体市場の成長に拍車をかけています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場：金利、インフレ、地政学、コロナ禍、回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界血漿誘導体PESTEL分析（政治、社会、技術、環境、法的要因、促進要因、抑制要因）
• 最終用途産業の分析
• 世界の血漿誘導体市場：成長率分析
• 世界の血漿誘導体市場の実績：規模と成長, 2019-2024
• 世界の血漿誘導体市場の予測：規模と成長, 2024-2029, 2034F
• 世界血漿誘導体総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の血漿誘導体市場：タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• アルブミン
• 第VIII因子
• 第IX因子
• 免疫グロブリン
• 高度免疫グロブリン
• その他のタイプ
• 世界の血漿誘導体市場：用途別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 血友病
• 低ガンマグロブリン血症
• 免疫不全疾患
• フォン・ヴィレブランド病
• その他の用途
• 世界の血漿誘導体市場：エンドユーザー別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 病院
• クリニック
• その他のエンドユーザー
• 世界の血漿誘導体市場、アルブミンの種類別のサブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• ヒト血清アルブミン
• 組み換えアルブミン
• 世界の血漿誘導体市場、タイプ別因子VIIIのサブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 血漿由来因子VIII
• 組み換え因子VIII
• 世界の血漿誘導体市場、因子IXのサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 血漿由来因子IX
• 組み換え因子IX
• 世界の血漿誘導体市場、免疫グロブリンのサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 静脈内免疫グロブリン（IVIG）
• 皮下免疫グロブリン（SCIG）
• 世界の血漿誘導体市場、高免疫グロブリンのサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 特定病原体低減高度免疫グロブリン
• 標準高度免疫グロブリン
• 世界の血漿誘導体市場、その他のタイプのサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• フィブリノーゲン
• 凝固因子濃縮物
• 血漿由来タンパク質

第7章 地域別・国別分析

• 世界の血漿誘導体市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界の血漿誘導体市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 血漿誘導体市場：競合情勢
• 血漿誘導体市場：企業プロファイル
  • Bayer AG Overview, Products and Services, Strategy and Financial Analysis
  • Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis
  • Takeda Pharmaceutical Company Limited Overview, Products and Services, Strategy and Financial Analysis
  • Baxter International Inc. Overview, Products and Services, Strategy and Financial Analysis
  • CSL Limited Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Meiji Group
• Grifols S.A.
• Shire Pharmaceuticals Inc.
• GC Biopharma Corp
• Emergent BioSolutions Inc.
• Shanghai Raas Blood Products Co Ltd.
• Kedrion S.p.A.
• Sanquin
• Biotest AG
• Bio Products Ltd.
• ADMA Biologics Inc.
• China Biologic Products Holdings Inc.
• BioIVT
• PlasmaGen BioSciences Pvt. Ltd.
• Virchow Biotech Private Limited

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 血漿誘導体市場2029：新たな機会を提供する国
• 血漿誘導体市場2029：新たな機会を提供するセグメント
• 血漿誘導体市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Blood plasma derivatives are pharmaceutical products derived from refined proteins found in blood plasma, including clotting factors, albumins, and other proteins. These derivatives play a crucial role in medical treatment by replenishing deficient or absent proteins within the body.

The primary types of blood plasma derivatives include albumin, factor VIII, factor IX, immunoglobulin, hyperimmune globulin, and others. Albumin is a key protein present in these derivatives, contributing to the regulation of osmotic pressure in the blood and aiding in the transportation of hormones, metals, and other molecules throughout the body. These derivatives find application in various medical conditions such as hemophilia, hypogammaglobulinemia, immunodeficiency diseases, von Willebrand's disease, and more. They are utilized by diverse end-users, including hospitals, clinics, and other healthcare institutions.

The blood plasma derivatives market research report is one of a series of new reports from The Business Research Company that provides blood plasma derivatives market statistics, including blood plasma derivatives industry global market size, regional shares, competitors with a blood plasma derivatives market share, detailed blood plasma derivatives market segments, market trends and opportunities, and any further data you may need to thrive in the blood plasma derivatives industry. This blood plasma derivatives market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The blood plasma derivatives market size has grown strongly in recent years. It will grow from $51.81 billion in 2024 to $56.24 billion in 2025 at a compound annual growth rate (CAGR) of 8.6%. The growth in the historic period can be attributed to increased prevalence of hemophilia and bleeding disorders, growth in geriatric population, increased awareness and diagnosis, rise in surgical procedures, global blood transfusion services

The blood plasma derivatives market size is expected to see strong growth in the next few years. It will grow to $80.42 billion in 2029 at a compound annual growth rate (CAGR) of 9.4%. The growth in the forecast period can be attributed to emergence of rare diseases therapies, growth in chronic diseases, increasing healthcare expenditure, patient-centric treatment approaches, growing healthcare infrastructure. Major trends in the forecast period include advancements in fractionation technologies, patient-centric approaches, collaborations and partnerships, expanding applications in neurology, technological innovations in plasma fractionation.

The rising incidence of immunodeficiency disorders is anticipated to drive the growth of the blood plasma derivatives market. Immunodeficiency disorders are conditions that either fully or partially weaken the immune system. Blood plasma derivatives are utilized in the treatment of various medical conditions, including immune deficiency disorders. Plasma, which is composed of proteins and salts, contains over 100 different proteins, with immunoglobulins being particularly important for treating primary immunodeficiencies. Factors like poor nutrition or malnutrition can result in macro- and micronutrient deficiencies, leading to immunodeficiency. For example, in March 2022, the Allergy, Asthma & Clinical Immunology reported that the most prevalent condition was Common Variable Immunodeficiency (CVID), affecting 16.6% of individuals in the US, 12.9% internationally, and 13.9% globally. Therefore, the increasing prevalence of immune deficiency disorders is contributing to the growth of the blood plasma derivatives market.

The rise in trauma and accident cases is expected to further accelerate the growth of the blood plasma derivatives market. Trauma and accident cases involve situations where individuals suffer physical injuries or harm due to unexpected incidents. Blood plasma derivatives are employed in these scenarios to replace clotting factors, treat hemorrhagic shock, assist in hemostasis and coagulation control, provide fluid replacement, support wound healing, and manage edema while maintaining fluid balance. For instance, in April 2024, the National Highway Traffic Safety Administration, a US government agency, reported that in 2022, 3,308 people were killed, and approximately 289,310 were injured in crashes involving distracted drivers. Thus, the increasing incidence of trauma and accident cases is fueling the growth of the blood plasma derivatives market.

The projected increase in the prevalence of hemophilia is set to be a significant driver propelling the growth of the blood plasma derivatives market. Hemophilia, a hereditary bleeding disorder, hinders proper blood clotting, leading to both spontaneous bleeding and bleeding following injury or surgical procedures. Individuals experiencing hemostasis-related issues, whether hereditary or acquired, often benefit from blood plasma-derived products or medications to effectively manage hemostasis. Treatments for conditions such as hemophilia A, von Willebrand disease, and hemophilia B involve the use of factor VIII, factor VIII/vWF, and factor IX concentrates, respectively. Notably, statistics from the Centers for Disease Control and Prevention (CDC) in August 2022 reported 3.7 cases of hemophilia B and 12 cases of hemophilia A per 100,000 American males in the United States, with 1 in 5,617 male births affected by hemophilia B and 1 in 19,283 male births affected by hemophilia A. Thus, the escalating prevalence of hemophilia serves as a driving force behind the expansion of the blood plasma derivatives market.

Prominent entities within the blood plasma derivatives market are strategically engaging in partnerships to gain a competitive advantage. These strategic alliances aim to ensure patients in need have consistent access to crucial plasma-derived medications, addressing the growing demand for immunoglobulins in France and beyond. A noteworthy example occurred in January 2022 when Kedrion S.p.A., an Italy-based biopharmaceutical company specializing in plasma-derived therapies, collaborated with LPB, a UK-based pharmaceutical company specializing in biological medicinal products. Under this partnership, Kedrion will utilize plasma acquired in France by the Etablissement Francais du Sang (EFS) to manufacture immunoglobulins in Hungary. These immunoglobulins will supplement the current supply available to hospitals nationwide, complying with and operating under the supervision of French health authorities. This import from LFB in France will contribute to reinforcing the supply chain of crucial immunoglobulins, aiding in meeting the healthcare demands of patients.

In April 2022, Grifols S.A., a Spain-based leader in the production of plasma-derived medicines, successfully acquired Biotest AG for an undisclosed amount. This strategic acquisition positions Grifols to enhance the accessibility of plasma medicines for patients, accelerate and broaden its product portfolio, take ownership of the most extensive private European network of plasma facilities boasting 87 locations, and contribute to revenue growth and profitability expansion. Biotest AG, based in Germany, is recognized for its role as a producer of various human blood plasma-derived concentrates used in intensive care medicines

Major companies operating in the blood plasma derivatives market include Bayer AG, Sanofi S.A., Takeda Pharmaceutical Company Limited, Baxter International Inc., CSL Limited, Meiji Group, Grifols S.A., Shire Pharmaceuticals Inc., GC Biopharma Corp, Emergent BioSolutions Inc., Shanghai Raas Blood Products Co Ltd., Kedrion S.p.A., Sanquin, Biotest AG, Bio Products Ltd., ADMA Biologics Inc., China Biologic Products Holdings Inc., BioIVT, PlasmaGen BioSciences Pvt. Ltd., Virchow Biotech Private Limited, LFB S.A., Intas Pharmaceuticals Ltd., Octapharma Plasma

North America was the largest region in the blood plasma derivatives market in 2024. The regions covered in the blood plasma derivatives market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the blood plasma derivatives market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The blood plasma derivatives market consists of sales of fibrinogen, globulin, sodium, potassium, bicarbonate, and chloride. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Blood Plasma Derivatives Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on blood plasma derivatives market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for blood plasma derivatives ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The blood plasma derivatives market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Type: Albumin; Factor VIII; Factor IX; Immunoglobulin; Hyperimmune Globulin; Other Types
• 2) By Application: Hemophilia; Hypogammaglobulinemia; Immunodeficiency Diseases; Von Willebrand's Disease; Other Applications
• 3) By End-User: Hospitals; Clinics; Other End-Users
• Subsegments:
• 1) By Albumin: Human Serum Albumin; Recombinant Albumin
• 2) By Factor VIII: Plasma-Derived Factor VIII; Recombinant Factor VIII
• 3) By Factor IX: Plasma-Derived Factor IX; Recombinant Factor IX
• 4) By Immunoglobulin: Intravenous Immunoglobulin (IVIG); Subcutaneous Immunoglobulin (SCIG)
• 5) By Hyperimmune Globulin: Specific Pathogen-Reduced Hyperimmune Globulin; Standard Hyperimmune Globulin
• 6) By Other Types: Fibrinogen; Clotting Factor Concentrates; Plasma-Derived Proteins
• Companies Mentioned: Bayer AG; Sanofi S.A.; Takeda Pharmaceutical Company Limited; Baxter International Inc.; CSL Limited
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Blood Plasma Derivatives Market Characteristics

3. Blood Plasma Derivatives Market Trends And Strategies

4. Blood Plasma Derivatives Market - Macro Economic Scenario including the impact of Interest Rates, Inflation, Geopolitics and Covid And Recovery on the Market

5. Global Blood Plasma Derivatives Growth Analysis And Strategic Analysis Framework

• 5.1. Global Blood Plasma Derivatives PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Blood Plasma Derivatives Market Growth Rate Analysis
• 5.4. Global Blood Plasma Derivatives Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Blood Plasma Derivatives Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Blood Plasma Derivatives Total Addressable Market (TAM)

6. Blood Plasma Derivatives Market Segmentation

• 6.1. Global Blood Plasma Derivatives Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Albumin
• Factor VIII
• Factor IX
• Immunoglobulin
• Hyperimmune Globulin
• Other Types
• 6.2. Global Blood Plasma Derivatives Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hemophilia
• Hypogammaglobulinemia
• Immunodeficiency Diseases
• Von Willebrand's Disease
• Other Applications
• 6.3. Global Blood Plasma Derivatives Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Clinics
• Other End-Users
• 6.4. Global Blood Plasma Derivatives Market, Sub-Segmentation Of Albumin, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Human Serum Albumin
• Recombinant Albumin
• 6.5. Global Blood Plasma Derivatives Market, Sub-Segmentation Of Factor VIII, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Plasma-Derived Factor VIII
• Recombinant Factor VIII
• 6.6. Global Blood Plasma Derivatives Market, Sub-Segmentation Of Factor IX, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Plasma-Derived Factor IX
• Recombinant Factor IX
• 6.7. Global Blood Plasma Derivatives Market, Sub-Segmentation Of Immunoglobulin, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Intravenous Immunoglobulin (IVIG)
• Subcutaneous Immunoglobulin (SCIG)
• 6.8. Global Blood Plasma Derivatives Market, Sub-Segmentation Of Hyperimmune Globulin, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Specific Pathogen-Reduced Hyperimmune Globulin
• Standard Hyperimmune Globulin
• 6.9. Global Blood Plasma Derivatives Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Fibrinogen
• Clotting Factor Concentrates
• Plasma-Derived Proteins

7. Blood Plasma Derivatives Market Regional And Country Analysis

• 7.1. Global Blood Plasma Derivatives Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Blood Plasma Derivatives Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Blood Plasma Derivatives Market

• 8.1. Asia-Pacific Blood Plasma Derivatives Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Blood Plasma Derivatives Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Blood Plasma Derivatives Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Blood Plasma Derivatives Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Blood Plasma Derivatives Market

• 9.1. China Blood Plasma Derivatives Market Overview
• 9.2. China Blood Plasma Derivatives Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Blood Plasma Derivatives Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Blood Plasma Derivatives Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Blood Plasma Derivatives Market

• 10.1. India Blood Plasma Derivatives Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Blood Plasma Derivatives Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Blood Plasma Derivatives Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Blood Plasma Derivatives Market

• 11.1. Japan Blood Plasma Derivatives Market Overview
• 11.2. Japan Blood Plasma Derivatives Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Blood Plasma Derivatives Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Blood Plasma Derivatives Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Blood Plasma Derivatives Market

• 12.1. Australia Blood Plasma Derivatives Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Blood Plasma Derivatives Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Blood Plasma Derivatives Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Blood Plasma Derivatives Market

• 13.1. Indonesia Blood Plasma Derivatives Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Blood Plasma Derivatives Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Blood Plasma Derivatives Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Blood Plasma Derivatives Market

• 14.1. South Korea Blood Plasma Derivatives Market Overview
• 14.2. South Korea Blood Plasma Derivatives Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Blood Plasma Derivatives Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Blood Plasma Derivatives Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Blood Plasma Derivatives Market

• 15.1. Western Europe Blood Plasma Derivatives Market Overview
• 15.2. Western Europe Blood Plasma Derivatives Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Blood Plasma Derivatives Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Blood Plasma Derivatives Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Blood Plasma Derivatives Market

• 16.1. UK Blood Plasma Derivatives Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Blood Plasma Derivatives Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Blood Plasma Derivatives Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Blood Plasma Derivatives Market

• 17.1. Germany Blood Plasma Derivatives Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Blood Plasma Derivatives Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Blood Plasma Derivatives Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Blood Plasma Derivatives Market

• 18.1. France Blood Plasma Derivatives Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Blood Plasma Derivatives Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Blood Plasma Derivatives Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Blood Plasma Derivatives Market

• 19.1. Italy Blood Plasma Derivatives Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Blood Plasma Derivatives Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Blood Plasma Derivatives Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Blood Plasma Derivatives Market

• 20.1. Spain Blood Plasma Derivatives Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Blood Plasma Derivatives Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Blood Plasma Derivatives Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Blood Plasma Derivatives Market

• 21.1. Eastern Europe Blood Plasma Derivatives Market Overview
• 21.2. Eastern Europe Blood Plasma Derivatives Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Blood Plasma Derivatives Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Blood Plasma Derivatives Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Blood Plasma Derivatives Market

• 22.1. Russia Blood Plasma Derivatives Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Blood Plasma Derivatives Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Blood Plasma Derivatives Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Blood Plasma Derivatives Market

• 23.1. North America Blood Plasma Derivatives Market Overview
• 23.2. North America Blood Plasma Derivatives Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Blood Plasma Derivatives Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Blood Plasma Derivatives Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Blood Plasma Derivatives Market

• 24.1. USA Blood Plasma Derivatives Market Overview
• 24.2. USA Blood Plasma Derivatives Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Blood Plasma Derivatives Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Blood Plasma Derivatives Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Blood Plasma Derivatives Market

• 25.1. Canada Blood Plasma Derivatives Market Overview
• 25.2. Canada Blood Plasma Derivatives Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Blood Plasma Derivatives Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Blood Plasma Derivatives Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Blood Plasma Derivatives Market

• 26.1. South America Blood Plasma Derivatives Market Overview
• 26.2. South America Blood Plasma Derivatives Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Blood Plasma Derivatives Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Blood Plasma Derivatives Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Blood Plasma Derivatives Market

• 27.1. Brazil Blood Plasma Derivatives Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Blood Plasma Derivatives Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Blood Plasma Derivatives Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Blood Plasma Derivatives Market

• 28.1. Middle East Blood Plasma Derivatives Market Overview
• 28.2. Middle East Blood Plasma Derivatives Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Blood Plasma Derivatives Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Blood Plasma Derivatives Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Blood Plasma Derivatives Market

• 29.1. Africa Blood Plasma Derivatives Market Overview
• 29.2. Africa Blood Plasma Derivatives Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Blood Plasma Derivatives Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Blood Plasma Derivatives Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Blood Plasma Derivatives Market Competitive Landscape And Company Profiles

• 30.1. Blood Plasma Derivatives Market Competitive Landscape
• 30.2. Blood Plasma Derivatives Market Company Profiles
  • 30.2.1. Bayer AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Takeda Pharmaceutical Company Limited Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Baxter International Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. CSL Limited Overview, Products and Services, Strategy and Financial Analysis

31. Blood Plasma Derivatives Market Other Major And Innovative Companies

• 31.1. Meiji Group
• 31.2. Grifols S.A.
• 31.3. Shire Pharmaceuticals Inc.
• 31.4. GC Biopharma Corp
• 31.5. Emergent BioSolutions Inc.
• 31.6. Shanghai Raas Blood Products Co Ltd.
• 31.7. Kedrion S.p.A.
• 31.8. Sanquin
• 31.9. Biotest AG
• 31.10. Bio Products Ltd.
• 31.11. ADMA Biologics Inc.
• 31.12. China Biologic Products Holdings Inc.
• 31.13. BioIVT
• 31.14. PlasmaGen BioSciences Pvt. Ltd.
• 31.15. Virchow Biotech Private Limited

32. Global Blood Plasma Derivatives Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Blood Plasma Derivatives Market

34. Recent Developments In The Blood Plasma Derivatives Market

35. Blood Plasma Derivatives Market High Potential Countries, Segments and Strategies

• 35.1 Blood Plasma Derivatives Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Blood Plasma Derivatives Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Blood Plasma Derivatives Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer